Grandfield & Dodd’s Celgene Corp CELG Stock Holding History

Grandfield & Dodd’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,370	Closed	-$211K	–	182
2018 Q1	$211K	Buy	2,370 +120	+5%	+$11.5K	0.02%	172
2017 Q4	$235K	Hold	2,250	–	–	0.03%	171
2017 Q3	$328K	Sell	2,250 -380	-14%	-$51.8K	0.04%	152
2017 Q2	$342K	Hold	2,630	–	–	0.04%	151
2017 Q1	$327K	Hold	2,630	–	–	0.04%	152
2016 Q4	$304K	Hold	2,630	–	–	0.04%	157
2016 Q3	$275K	Sell	2,630 -555	-17%	-$60.1K	0.04%	161
2016 Q2	$314K	Hold	3,185	–	–	0.04%	146
2016 Q1	$319K	Hold	3,185	–	–	0.05%	139
2015 Q4	$381K	Hold	3,185	–	–	0.06%	126
2015 Q3	$345K	Buy	3,185 +1,143	+56%	+$142K	0.06%	130
2015 Q2	$236K	Sell	2,042 -330	-14%	-$37.7K	0.04%	156
2015 Q1	$273K	Hold	2,372	–	–	0.04%	145
2014 Q4	$265K	Hold	2,372	–	–	0.04%	145
2014 Q3	$225K	Hold	2,372	–	–	0.04%	151
2014 Q2	$204K	Buy	+2,372	New	+$180K	0.03%	173
2014 Q1	–	Sell	-2,372	Closed	-$200K	–	182
2013 Q4	$200K	Buy	+2,372	New	+$188K	0.03%	169

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Grandfield & Dodd's CELG Position: Q2 2018 in Review

Grandfield & Dodd sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 2,370 shares — an estimated $211K sold.

Grandfield & Dodd first reported a position in CELG in Q4 2013 and held it in 17 quarters. The position peaked at $381K in Q4 2015. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

Grandfield & Dodd reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
Grandfield & Dodd sold 2,370 Celgene Corp shares in Q2 2018, an estimated $211K.
Grandfield & Dodd first reported a position in Celgene Corp in Q4 2013 and held it in 17 quarters.
Grandfield & Dodd's Celgene Corp position peaked at $381K in Q4 2015.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Grandfield & Dodd's 13F filing for Q2 2018, filed 27 Jul 2018.